Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.79) by 44.51 percent. This is a 8.33 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $232.09 million which beat the analyst consensus estimate of $211.26 million by 9.86 percent. This is a 30.95 percent increase over sales of $177.24 million the same period last year.
精彩评论